Govt assures support to enhance efficiency & productivity of pharma PSUs
Updated: Aug 06, 2015 02:15:58pm
Gurgaon, August 6 (KNN) The Union Minister of Chemicals and Fertilizers, Ananth Kumar assured government’s full support in enhancing the efficiency and productivity of the public sector undertaking pharmaceutical companies. He said that providing affordable and good quality medicines to masses of the country is important and the PSUs have an important role to play as they are not driven by profit motive but also serve public interest.
Inaugurating the Modernised General Tablet Section of Indian Drugs and Pharmaceuticals Limited (IDPL) Gurgaon Plant on Wednesday, the minister said the Department of Pharmaceuticals is working on ‘Make-In-India’ mantra and this unit of IDPL is a step in that direction.
The Gurgaon Plant has been upgraded at the cost of Rs 3 Crore as per “Revised Sch -M” requirement and GMP certificate has been obtained.
Assuring that the PSUs will not be sold, Kumar informed that a model will be developed for leveraging their assets to make them financially sustainable.
A task force will be set up soon to look into all these aspects and the ministry is working in close coordination with others concerned departments of central and state governments as team India to attain health security, he said.
The minister also said that Jan Aushadhi will be revamped soon. He informed that pharma cluster, pharma parks and medical devices parks are also a step in this direction.
The Minister of State for Chemicals and Fertilizers, Hansraj Gangaram Ahir and Secretary, Department of Pharmaceuticals, VK Subburaj were also present in the occasion.
Subburak said the government is taking policy initiatives so that more and more Indian Pharmaceutical companies become compliant to the WHO quality standards. He said that the drugs provided by IDPL and other PSUs will facilitate in smooth functioning of the government’s programmes and help provide access to people of good quality medicines.
After Modernisation, IDPL-Gurgaon plant will be able to launch new products in the field of Diabetes, Oncology, NSAIDS, Antibiotics-3rd Generation, Nephrology and Cardiology including other segments of lifestyle diseases at affordable price and will play a vital role in providing medicines at reasonable rate for the common people. (KNN Bureau)
Inaugurating the Modernised General Tablet Section of Indian Drugs and Pharmaceuticals Limited (IDPL) Gurgaon Plant on Wednesday, the minister said the Department of Pharmaceuticals is working on ‘Make-In-India’ mantra and this unit of IDPL is a step in that direction.
The Gurgaon Plant has been upgraded at the cost of Rs 3 Crore as per “Revised Sch -M” requirement and GMP certificate has been obtained.
Assuring that the PSUs will not be sold, Kumar informed that a model will be developed for leveraging their assets to make them financially sustainable.
A task force will be set up soon to look into all these aspects and the ministry is working in close coordination with others concerned departments of central and state governments as team India to attain health security, he said.
The minister also said that Jan Aushadhi will be revamped soon. He informed that pharma cluster, pharma parks and medical devices parks are also a step in this direction.
The Minister of State for Chemicals and Fertilizers, Hansraj Gangaram Ahir and Secretary, Department of Pharmaceuticals, VK Subburaj were also present in the occasion.
Subburak said the government is taking policy initiatives so that more and more Indian Pharmaceutical companies become compliant to the WHO quality standards. He said that the drugs provided by IDPL and other PSUs will facilitate in smooth functioning of the government’s programmes and help provide access to people of good quality medicines.
After Modernisation, IDPL-Gurgaon plant will be able to launch new products in the field of Diabetes, Oncology, NSAIDS, Antibiotics-3rd Generation, Nephrology and Cardiology including other segments of lifestyle diseases at affordable price and will play a vital role in providing medicines at reasonable rate for the common people. (KNN Bureau)
Loading...
